title: Therapy for metastatic ESFT: is it time to ask new questions?
authors.affiliation: Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892, USA.
authors.forename: Kristen M
authors.initials: KM
authors.lastname: Snyder
authors.forename: Crystal L
authors.initials: CL
authors.lastname: Mackall
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000473:pathology; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D006801:Humans; D015337:Multicenter Studies as Topic; D018242:Neuroectodermal Tumors, Primitive / Q000188:drug therapy / Q000556:secondary / Q000601:surgery; D036102:Peripheral Blood Stem Cell Transplantation; D010865:Pilot Projects; D012512:Sarcoma, Ewing / Q000188:drug therapy / Q000556:secondary* / Q000601:surgery; D014182:Transplantation, Autologous; D016896:Treatment Outcome
chemical_list: D018906:Antineoplastic Agents, Alkylating